12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      THE COMMON COLD

      research-article
      , MD *
      Primary Care
      W. B. Saunders Company. Published by Elsevier Inc.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The common cold has intrigued physicians and the general public for centuries. It has been defined as an acute epidemic respiratory disease characterized by mild coryzal symptoms of rhinorrhea, nasal obstruction, and sneezing. The nasal discharge is usually copious and thin during the first 2 days of illness, then it generally becomes more viscous and purulent. 22 The disease is self-limited. Symptoms may persist for 2 days to more than 14 days; however, the cold may abort after only 1 day. Fever, cough, sore throat, or lacrimation may or may not be present. The common cold is of itself harmless, but bacterial invasion frequently follows the initial infection. It is these secondary invaders that may produce disorders of serious consequence.

          The common cold is the most frequent acute illness in the United States and throughout the industrialized world. About half the population gets at least one cold every year. 5 Colds account for 40% of all time lost from jobs among employed people (23 million days of work per year) and about 30% of absenteeism from schools (26 million school days per year). Estimates vary, but the average preschool child has somewhere between 4 and 10 colds per year, and the average adult has about two to four colds per year. The actual cost of caring for patients with colds in US physicians' offices is estimated to be $1.5 billion annually. 64

          Seasonal patterns of infection can be identified for some of the various types of viruses that are responsible for outbreaks of the common cold. For example, available epidemiologic data suggest early fall and late spring are the most common times to find more outbreaks of rhinovirus. Respiratory syncytial virus (RSV) tends to follow winter and spring incidence, with a peak number of cases found mainly in January. Parainfluenza types 1 and 2 seem to peak during the autumn, whereas parainfluenza type 3 has an increased incidence during the late spring. Adenoviruses and coronaviruses tend to produce epidemics during the winter and spring (Fig. 1)

          This article presents data concerning the cause, pathogenesis, and treatment of the common cold, as well as discussion of the available diagnostic tests and their use in formulating differential diagnoses.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          Acute respiratory illness in the community. Frequency of illness and the agents involved.

          Investigations of respiratory illnesses and infections in Tecumseh, Michigan, USA, were carried out in two phases, together covering 11 years. During the second phase, there were 5363 person-years of observation. Respiratory illness rates in both males and females peaked in the 1-2 year age group and fell thereafter. Adult females had more frequent illnesses than adult males; illnesses were less common in working women than in women not working outside the home. Isolation of viruses fell with increasing age; rhinoviruses were the most common isolate. Influenza infection rates, determined serologically, suggested relative sparing of young children from infection with type A (H1N1) and type B. Infection rates were highest in adult age groups for type A (H3N2). The isolation and serological infection rates were used to estimate the extent to which laboratory procedures underestimated the proportion of respiratory illnesses caused by each infectious agent; data from other studies were also used in this estimation. Severity of respiratory illnesses was assessed by the proportion of such illnesses that resulted in consultation of a physician. Rhinoviruses produced the greatest number of consultations. Overall, physician consultations were associated with 25.4% of respiratory illnesses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Transmission of experimental rhinovirus infection by contaminated surfaces.

            Transfer of experimental rhinovirus infection by an intermediary environmental surface was examined in healthy young adults, in four studies done in 1980--1981, by having recipients handle surfaces previously contaminated by infected donors. Recipients touched their nasal and conjunctival mucosa after touching the surfaces. Five (50%) of 10 recipients developed infection after exposure to virus-contaminated coffee cup handles and nine (56%) of 16 became infected after exposure to contaminated plastic tiles. Spraying of contaminated tiles with a commercially available phenol/alcohol disinfectant reduced (p = 0.003) the rate of recovery of virus from the tiles from 42% (20/47) to 8% (2/26). Similarly, the rate of detection of virus on fingers touching the tiles was reduced (p = 0.001) from 61% (28/46) with unsprayed tiles to 21% (11/53) with sprayed tiles. Fifty-six per cent (9/16) of the recipients exposed on three consecutive days to untreated tiles became infected while 35% (7/20) touching only sprayed tiles became infected with rhinovirus (p = 0.3). These studies indicate that experimental rhinovirus colds can be spread by way of contaminated environmental surfaces and suggest that disinfectant treatment of such surfaces may reduce risk of viral transmission by this route.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers.

              A double-blind, placebo-controlled trial was conducted to study the effects of over-the-counter analgesic/antipyretic medications on virus shedding, immune response, and clinical status in the common cold. Sixty healthy volunteers were challenged intranasally with rhinovirus type 2 and randomized to one of four treatment arms: aspirin, acetaminophen, ibuprofen, or placebo. Fifty-six volunteers were successfully infected and shed virus on at least 4 days after challenge. Virus shedding, antibody levels, clinical symptoms and signs, and blood leukocyte levels were carefully monitored. Use of aspirin and acetaminophen was associated with suppression of serum neutralizing antibody response (P less than .05 vs. placebo) and increased nasal symptoms and signs (P less than .05 vs. placebo). A concomitant rise in circulating monocytes suggested that the suppression of antibody response may be mediated through drug effects on monocytes and/or mononuclear phagocytes. There were no significant differences in viral shedding among the four groups, but a trend toward longer duration of virus shedding was observed in the aspirin and acetaminophen groups.
                Bookmark

                Author and article information

                Journal
                Prim Care
                Prim. Care
                Primary Care
                W. B. Saunders Company. Published by Elsevier Inc.
                0095-4543
                1558-299X
                24 June 2005
                1 December 1996
                24 June 2005
                : 23
                : 4
                : 657-675
                Author notes
                [*]

                From the Department of Family Practice and Community Medicine, University of South Alabama College of Medicine, Mobile, Alabama

                Article
                S0095-4543(05)70355-9
                10.1016/S0095-4543(05)70355-9
                7125839
                8890137
                36eb0f70-89a1-47e1-be47-94abb6a426f5
                © 1996 W. B. Saunders Company

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Comments

                Comment on this article